Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "Medical"

3105 News Found

Merck doses first patient in Phase 3 trial of novel antibody-drug conjugate for metastatic colorectal cancer
Clinical Trials | May 23, 2026

Merck doses first patient in Phase 3 trial of novel antibody-drug conjugate for metastatic colorectal cancer

The trial will assess Precem-TcT, both as monotherapy and in combination with bevacizumab, in patients whose disease has progressed after or become resistant to standard treatments


Health ministry classifies Pregabalin under Schedule H1 to curb misuse
Policy | May 23, 2026

Health ministry classifies Pregabalin under Schedule H1 to curb misuse

New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain


ABDM crosses 100 crore ABHA-linked health records milestone
Digitisation | May 23, 2026

ABDM crosses 100 crore ABHA-linked health records milestone

More than 450 public and private health technology solutions have integrated with the Ayushman Bharat Digital Mission ecosystem


OncoSil secures TGA approval for pancreatic cancer device
News | May 22, 2026

OncoSil secures TGA approval for pancreatic cancer device

Approval of device in Australia for treating locally advanced pancreatic cancer alongside gemcitabine-based chemotherapy


Multimodal AI emerges as next leap in predictive healthcare: Ashwattha Sahasrabuddhe, Principal Architect and Technology & Practice Head – Healthcare Business, Tata Elxsi
Opinion | May 22, 2026

Multimodal AI emerges as next leap in predictive healthcare: Ashwattha Sahasrabuddhe, Principal Architect and Technology & Practice Head – Healthcare Business, Tata Elxsi

Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond


Lupin enters China market with approval for Oseltamivir oral suspension
Drug Approval | May 22, 2026

Lupin enters China market with approval for Oseltamivir oral suspension

The approval has been secured in partnership with Yabao Pharmaceuticals, a major player in China’s paediatric medicine segment


APHI welcomes CCI order on integrated healthcare delivery model
Healthcare | May 22, 2026

APHI welcomes CCI order on integrated healthcare delivery model

The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices


QIAGEN and NVIDIA partner on AI drug discovery
R&D | May 21, 2026

QIAGEN and NVIDIA partner on AI drug discovery

Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases


Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115 million deal
News | May 21, 2026

Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115 million deal

SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization


ZenMD launches India-focused clinical AI platform for doctors and hospitals
Digitisation | May 21, 2026

ZenMD launches India-focused clinical AI platform for doctors and hospitals

Solutions designed to help clinicians reduce administrative burden, improve diagnostic accuracy, and spend more time with patients